메뉴 건너뛰기




Volumn 47, Issue 1, 2012, Pages 75-91

The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice

Author keywords

Akinesia; Huntington's disease; MGluR2 3; Striatum; Therapy

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID;

EID: 84861228589     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.03.025     Document Type: Article
Times cited : (37)

References (174)
  • 2
    • 0025321039 scopus 로고
    • Functional architecture of basal ganglia circuits: neural substrates of parallel processing
    • Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990, 13:266-271.
    • (1990) Trends Neurosci. , vol.13 , pp. 266-271
    • Alexander, G.E.1    Crutcher, M.D.2
  • 3
    • 84861231656 scopus 로고    scopus 로고
    • Allen Brain Atlas
    • Allen Brain Atlas http://mouse.brain-map.org/welcome.do.
  • 5
    • 33646167406 scopus 로고    scopus 로고
    • Altered cortical glutamate receptor function in the r6/2 model of Huntington's disease
    • Andre V.M., Cepeda C., Venegas A., Gomez Y., Levine M.S. Altered cortical glutamate receptor function in the r6/2 model of Huntington's disease. J. Neurophysiol. 2006, 95:2108-2119.
    • (2006) J. Neurophysiol. , vol.95 , pp. 2108-2119
    • Andre, V.M.1    Cepeda, C.2    Venegas, A.3    Gomez, Y.4    Levine, M.S.5
  • 6
    • 34547735547 scopus 로고    scopus 로고
    • NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner
    • Arning L., Saft C., Wieczorek S., Andrich J., Kraus P.H., Epplen J.T. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner. Hum. Genet. 2007, 122:175-182.
    • (2007) Hum. Genet. , vol.122 , pp. 175-182
    • Arning, L.1    Saft, C.2    Wieczorek, S.3    Andrich, J.4    Kraus, P.H.5    Epplen, J.T.6
  • 7
    • 7244236320 scopus 로고    scopus 로고
    • Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
    • Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431:805-810.
    • (2004) Nature , vol.431 , pp. 805-810
    • Arrasate, M.1    Mitra, S.2    Schweitzer, E.S.3    Segal, M.R.4    Finkbeiner, S.5
  • 8
    • 0030708576 scopus 로고    scopus 로고
    • Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-an in situ hybridization study
    • Arzberger T., Krampfl K., Leimgruber S., Weindl A. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-an in situ hybridization study. J. Neuropathol. Exp. Neurol. 1997, 56:440-454.
    • (1997) J. Neuropathol. Exp. Neurol. , vol.56 , pp. 440-454
    • Arzberger, T.1    Krampfl, K.2    Leimgruber, S.3    Weindl, A.4
  • 9
    • 0026556331 scopus 로고
    • Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light-microscopic distinction from polymyositis
    • Askanas V., Serdaroglu P., Engel W.K., Alvarez R.B. Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light-microscopic distinction from polymyositis. Neurology 1992, 42:460-461.
    • (1992) Neurology , vol.42 , pp. 460-461
    • Askanas, V.1    Serdaroglu, P.2    Engel, W.K.3    Alvarez, R.B.4
  • 10
    • 2442506955 scopus 로고    scopus 로고
    • Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor
    • Baquet Z.C., Gorski J.A., Jones K.R. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J. Neurosci. 2004, 24:4250-4258.
    • (2004) J. Neurosci. , vol.24 , pp. 4250-4258
    • Baquet, Z.C.1    Gorski, J.A.2    Jones, K.R.3
  • 11
    • 0030852182 scopus 로고    scopus 로고
    • In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
    • Battaglia G., Monn J.A., Schoepp D.D. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci. Lett. 1997, 229:161-164.
    • (1997) Neurosci. Lett. , vol.229 , pp. 161-164
    • Battaglia, G.1    Monn, J.A.2    Schoepp, D.D.3
  • 13
    • 0026043565 scopus 로고
    • Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
    • Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 1991, 11:1649-1659.
    • (1991) J. Neurosci. , vol.11 , pp. 1649-1659
    • Beal, M.F.1    Ferrante, R.J.2    Swartz, K.J.3    Kowall, N.W.4
  • 14
    • 0036345741 scopus 로고    scopus 로고
    • Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation
    • Behrens P.F., Franz P., Woodman B., Lindenberg K.S., Landwehrmeyer G.B. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002, 125:1908-1922.
    • (2002) Brain , vol.125 , pp. 1908-1922
    • Behrens, P.F.1    Franz, P.2    Woodman, B.3    Lindenberg, K.S.4    Landwehrmeyer, G.B.5
  • 15
    • 0029794358 scopus 로고    scopus 로고
    • NeuN: a useful neuronal marker for diagnostic histopathology
    • Bluhmke I. NeuN: a useful neuronal marker for diagnostic histopathology. J. Histochem. Cytochem. 1996, 44:1167-1171.
    • (1996) J. Histochem. Cytochem. , vol.44 , pp. 1167-1171
    • Bluhmke, I.1
  • 16
    • 0347626155 scopus 로고    scopus 로고
    • Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice
    • Bolivar V.J., Manley K., Messer A. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behav. Neurosci. 2003, 117:1233-1242.
    • (2003) Behav. Neurosci. , vol.117 , pp. 1233-1242
    • Bolivar, V.J.1    Manley, K.2    Messer, A.3
  • 17
    • 0032822044 scopus 로고    scopus 로고
    • LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal cerebral ischemia
    • Bond A., Ragumoorthy N., Monn J.A., Hick C.A., Ward M.A., Lodge D., O'Neill M.J. LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal cerebral ischemia. Neurosci. Lett. 1999, 273:191-194.
    • (1999) Neurosci. Lett. , vol.273 , pp. 191-194
    • Bond, A.1    Ragumoorthy, N.2    Monn, J.A.3    Hick, C.A.4    Ward, M.A.5    Lodge, D.6    O'Neill, M.J.7
  • 19
    • 0026054608 scopus 로고
    • Asymmetric increase in substance P immunoreactivity in the rat and guinea pig substantia nigra after unilateral neocortical ablation
    • Bouras C., Vallet P.G., Hof P.R. Asymmetric increase in substance P immunoreactivity in the rat and guinea pig substantia nigra after unilateral neocortical ablation. Neurosci. Lett. 1991, 133:53-56.
    • (1991) Neurosci. Lett. , vol.133 , pp. 53-56
    • Bouras, C.1    Vallet, P.G.2    Hof, P.R.3
  • 20
    • 0031032470 scopus 로고    scopus 로고
    • The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling
    • Bruno V., Sureda F.X., Storto M., Casabona G., Caruso A., Knopfel T., Kuhn R., Nicoletti F. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling. J. Neurosci. 1997, 17:1891-1897.
    • (1997) J. Neurosci. , vol.17 , pp. 1891-1897
    • Bruno, V.1    Sureda, F.X.2    Storto, M.3    Casabona, G.4    Caruso, A.5    Knopfel, T.6    Kuhn, R.7    Nicoletti, F.8
  • 21
    • 0032403407 scopus 로고    scopus 로고
    • Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta
    • Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F., Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J. Neurosci. 1998, 18:9594-9600.
    • (1998) J. Neurosci. , vol.18 , pp. 9594-9600
    • Bruno, V.1    Battaglia, G.2    Casabona, G.3    Copani, A.4    Caciagli, F.5    Nicoletti, F.6
  • 22
    • 0033576789 scopus 로고    scopus 로고
    • Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist
    • Cai Z., Xiao F., Fratkin J.D., Rhodes P.G. Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist. Neuroreport 1999, 10:3927-3931.
    • (1999) Neuroreport , vol.10 , pp. 3927-3931
    • Cai, Z.1    Xiao, F.2    Fratkin, J.D.3    Rhodes, P.G.4
  • 23
    • 4444350918 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease
    • Canals J.M., Pineda J.R., Torres-Peraza J.F., Bosch M., Martin-Ibanez R., Muñoz M.T., Mengod G., Ernfors P., Alberch J. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci. 2004, 24:7727-7739.
    • (2004) J. Neurosci. , vol.24 , pp. 7727-7739
    • Canals, J.M.1    Pineda, J.R.2    Torres-Peraza, J.F.3    Bosch, M.4    Martin-Ibanez, R.5    Muñoz, M.T.6    Mengod, G.7    Ernfors, P.8    Alberch, J.9
  • 24
    • 0033819849 scopus 로고    scopus 로고
    • Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene
    • Carter R.J., Hunt M.J., Morton A.J. Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene. Mov. Disord. 2000, 15:925-937.
    • (2000) Mov. Disord. , vol.15 , pp. 925-937
    • Carter, R.J.1    Hunt, M.J.2    Morton, A.J.3
  • 28
    • 0031002423 scopus 로고    scopus 로고
    • In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation
    • Charpier S., Deniau J.M. In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7036-7040.
    • (1997) Proc. Natl. Acad. Sci. U. S. A. , vol.94 , pp. 7036-7040
    • Charpier, S.1    Deniau, J.M.2
  • 29
    • 0030995878 scopus 로고    scopus 로고
    • Pharmacology and functions of metabotropic glutamate receptors
    • Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 1997, 37:205-237.
    • (1997) Annu. Rev. Pharmacol. Toxicol. , vol.37 , pp. 205-237
    • Conn, P.J.1    Pin, J.P.2
  • 31
    • 34547686245 scopus 로고    scopus 로고
    • The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection
    • Corti C., Battaglia G., Molinaro G., Riozzi B., Pittaluga A., Corsi M., Mugnaini M., Nicoletti F., Bruno V. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. J. Neurosci. 2007, 27:8297-8308.
    • (2007) J. Neurosci. , vol.27 , pp. 8297-8308
    • Corti, C.1    Battaglia, G.2    Molinaro, G.3    Riozzi, B.4    Pittaluga, A.5    Corsi, M.6    Mugnaini, M.7    Nicoletti, F.8    Bruno, V.9
  • 32
    • 33748577363 scopus 로고    scopus 로고
    • Selective neuronal degeneration in Huntington's disease
    • Cowan C.M., Raymond L.A. Selective neuronal degeneration in Huntington's disease. Curr. Top. Dev. Biol. 2006, 75:25-71.
    • (2006) Curr. Top. Dev. Biol. , vol.75 , pp. 25-71
    • Cowan, C.M.1    Raymond, L.A.2
  • 33
    • 0030873754 scopus 로고    scopus 로고
    • Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a new potent and selective antagonist
    • Cozzi A., Attucci S., Peruginelli F., Marinozzi M., Luneia R., Pellicciari R., Moroni F. Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a new potent and selective antagonist. Eur. J. Neurosci. 1997, 9:1350-1355.
    • (1997) Eur. J. Neurosci. , vol.9 , pp. 1350-1355
    • Cozzi, A.1    Attucci, S.2    Peruginelli, F.3    Marinozzi, M.4    Luneia, R.5    Pellicciari, R.6    Moroni, F.7
  • 34
    • 79551655290 scopus 로고    scopus 로고
    • Huntington's disease: can mice lead the way to treatment?
    • Crook Z.R., Housman D. Huntington's disease: can mice lead the way to treatment?. Neuron 2011, 69:423-435.
    • (2011) Neuron , vol.69 , pp. 423-435
    • Crook, Z.R.1    Housman, D.2
  • 35
    • 33749042331 scopus 로고    scopus 로고
    • Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
    • Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006, 127:59-69.
    • (2006) Cell , vol.127 , pp. 59-69
    • Cui, L.1    Jeong, H.2    Borovecki, F.3    Parkhurst, C.N.4    Tanese, N.5    Krainc, D.6
  • 36
    • 14744288140 scopus 로고    scopus 로고
    • Estrogen and cytokines production - the possible cause of gender differences in neurological diseases
    • Czlonkowska A., Ciesielska A., Gromadzka G., Kurkowska-Jastrzebska I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr. Pharm. Des. 2005, 11:1017-1030.
    • (2005) Curr. Pharm. Des. , vol.11 , pp. 1017-1030
    • Czlonkowska, A.1    Ciesielska, A.2    Gromadzka, G.3    Kurkowska-Jastrzebska, I.4
  • 37
    • 0029149775 scopus 로고
    • Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones
    • Davies C.H., Clarke V.R., Jane D.E., Collingridge G.L. Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones. Br. J. Pharmacol. 1995, 116:1859-1869.
    • (1995) Br. J. Pharmacol. , vol.116 , pp. 1859-1869
    • Davies, C.H.1    Clarke, V.R.2    Jane, D.E.3    Collingridge, G.L.4
  • 39
    • 77957809832 scopus 로고    scopus 로고
    • Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease
    • Decressac M., Wright B., Tyers P., Gaillard A., Barker R.A. Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease. Exp. Neurol. 2010, 226:24-32.
    • (2010) Exp. Neurol. , vol.226 , pp. 24-32
    • Decressac, M.1    Wright, B.2    Tyers, P.3    Gaillard, A.4    Barker, R.A.5
  • 40
    • 0025298139 scopus 로고
    • Primate models of movement disorders of basal ganglia origin
    • DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990, 13:281-285.
    • (1990) Trends Neurosci. , vol.13 , pp. 281-285
    • DeLong, M.R.1
  • 41
    • 2942625910 scopus 로고    scopus 로고
    • Differential loss of striatal projection neurons in Huntington's disease: a quantitative immunohistochemical study
    • Deng Y.P., Penney J.B., Young A.B., Albin R.L., Anderson K.D., Reiner A. Differential loss of striatal projection neurons in Huntington's disease: a quantitative immunohistochemical study. J. Chem. Neuroanat. 2004, 27:143-164.
    • (2004) J. Chem. Neuroanat. , vol.27 , pp. 143-164
    • Deng, Y.P.1    Penney, J.B.2    Young, A.B.3    Albin, R.L.4    Anderson, K.D.5    Reiner, A.6
  • 42
    • 72749108602 scopus 로고    scopus 로고
    • Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain
    • Di Liberto V., Bonomo A., Frinchi M., Belluardo N., Mudo G. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain. Neuroscience 2010, 165:863-873.
    • (2010) Neuroscience , vol.165 , pp. 863-873
    • Di Liberto, V.1    Bonomo, A.2    Frinchi, M.3    Belluardo, N.4    Mudo, G.5
  • 43
    • 0030752709 scopus 로고    scopus 로고
    • Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
    • DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277:1990-1993.
    • (1997) Science , vol.277 , pp. 1990-1993
    • DiFiglia, M.1    Sapp, E.2    Chase, K.O.3    Davies, S.W.4    Bates, G.P.5    Vonsattel, J.P.6    Aronin, N.7
  • 45
    • 33846906945 scopus 로고    scopus 로고
    • Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease
    • Dorner J.L., Miller B.R., Barton S.J., Brock T.J., Rebec G.V. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav. Brain Res. 2007, 178:90-97.
    • (2007) Behav. Brain Res. , vol.178 , pp. 90-97
    • Dorner, J.L.1    Miller, B.R.2    Barton, S.J.3    Brock, T.J.4    Rebec, G.V.5
  • 46
    • 0033757718 scopus 로고    scopus 로고
    • Inactivation of the mouse Huntington's disease gene in the brain and testis results in progressive neurodegeneration and sterility
    • Dragatsis I., Levine M., Zeitlin S. Inactivation of the mouse Huntington's disease gene in the brain and testis results in progressive neurodegeneration and sterility. Nat. Genet. 2000, 26:300-306.
    • (2000) Nat. Genet. , vol.26 , pp. 300-306
    • Dragatsis, I.1    Levine, M.2    Zeitlin, S.3
  • 48
    • 0034829038 scopus 로고    scopus 로고
    • SEE: a tool for the visualization and analysis of rodent exploratory behavior
    • Drai D., Golani I. SEE: a tool for the visualization and analysis of rodent exploratory behavior. Neurosci. Biobehav. Rev. 2001, 25:409-426.
    • (2001) Neurosci. Biobehav. Rev. , vol.25 , pp. 409-426
    • Drai, D.1    Golani, I.2
  • 49
    • 0034654483 scopus 로고    scopus 로고
    • Statistical discrimination of natural modes of motion in rat exploratory behavior
    • Drai D., Benjamini Y., Golani I. Statistical discrimination of natural modes of motion in rat exploratory behavior. J. Neurosci. Methods 2000, 96:119-131.
    • (2000) J. Neurosci. Methods , vol.96 , pp. 119-131
    • Drai, D.1    Benjamini, Y.2    Golani, I.3
  • 50
    • 34047100940 scopus 로고    scopus 로고
    • N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
    • Fan M.M., Raymond L.A. N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol. 2007, 81:272-293.
    • (2007) Prog. Neurobiol. , vol.81 , pp. 272-293
    • Fan, M.M.1    Raymond, L.A.2
  • 51
    • 34147112751 scopus 로고    scopus 로고
    • Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease
    • Fan M.M., Fernandes H.B., Zhang L.Y., Hayden M.R., Raymond L.A. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease. J. Neurosci. 2007, 27:3768-3779.
    • (2007) J. Neurosci. , vol.27 , pp. 3768-3779
    • Fan, M.M.1    Fernandes, H.B.2    Zhang, L.Y.3    Hayden, M.R.4    Raymond, L.A.5
  • 54
    • 0028114866 scopus 로고
    • Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats
    • Figueredo-Cardenas G., Anderson K.D., Chen Q., Veeman C.L., Reiner A. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats. Exp. Neurol. 1994, 129:37-56.
    • (1994) Exp. Neurol. , vol.129 , pp. 37-56
    • Figueredo-Cardenas, G.1    Anderson, K.D.2    Chen, Q.3    Veeman, C.L.4    Reiner, A.5
  • 56
    • 41749083721 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice
    • Gharami K., Xie Y., An J.J., Tonegawa S., Xu B. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J. Neurochem. 2008, 105:369-379.
    • (2008) J. Neurochem. , vol.105 , pp. 369-379
    • Gharami, K.1    Xie, Y.2    An, J.J.3    Tonegawa, S.4    Xu, B.5
  • 57
    • 60549103857 scopus 로고    scopus 로고
    • The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease
    • Gil J.M., Rego A.C. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease. Brain Res. Rev. 2009, 59:410-431.
    • (2009) Brain Res. Rev. , vol.59 , pp. 410-431
    • Gil, J.M.1    Rego, A.C.2
  • 58
    • 80053613635 scopus 로고    scopus 로고
    • Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
    • Giralt A., Carretón O., Lao-Peregrin C., Eduardo D., Martín E.D., Alberch J. Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol. Neurodegener. 2011, 6:71-86.
    • (2011) Mol. Neurodegener. , vol.6 , pp. 71-86
    • Giralt, A.1    Carretón, O.2    Lao-Peregrin, C.3    Eduardo, D.4    Martín, E.D.5    Alberch, J.6
  • 59
    • 0034081681 scopus 로고    scopus 로고
    • The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease
    • Glass M., Dragunow M., Faull R.L.M. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 2000, 97:505-519.
    • (2000) Neuroscience , vol.97 , pp. 505-519
    • Glass, M.1    Dragunow, M.2    Faull, R.L.M.3
  • 60
    • 0042133327 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites
    • Gorski J.A., Zeiler S.R., Tamowski S., Jones K.R. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J. Neurosci. 2003, 23:6856-6865.
    • (2003) J. Neurosci. , vol.23 , pp. 6856-6865
    • Gorski, J.A.1    Zeiler, S.R.2    Tamowski, S.3    Jones, K.R.4
  • 64
    • 3242748968 scopus 로고    scopus 로고
    • Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease
    • Hannan A.J. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease. Acta Biochim. Pol. 2004, 51:415-430.
    • (2004) Acta Biochim. Pol. , vol.51 , pp. 415-430
    • Hannan, A.J.1
  • 65
    • 0033587760 scopus 로고    scopus 로고
    • Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
    • Hansson O., Peterson A., Leist M., Nicotera P., Castilho R.F., Brundin P. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8727-8732.
    • (1999) Proc. Natl. Acad. Sci. U. S. A. , vol.96 , pp. 8727-8732
    • Hansson, O.1    Peterson, A.2    Leist, M.3    Nicotera, P.4    Castilho, R.F.5    Brundin, P.6
  • 66
    • 0035783462 scopus 로고    scopus 로고
    • Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene
    • Hansson O., Guatteo E., Mercuri N.B., Bernardi G., Li X.J., Castilho R.F., Brundin P. Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene. Eur. J. Neurosci. 2001, 14:1492-1504.
    • (2001) Eur. J. Neurosci. , vol.14 , pp. 1492-1504
    • Hansson, O.1    Guatteo, E.2    Mercuri, N.B.3    Bernardi, G.4    Li, X.J.5    Castilho, R.F.6    Brundin, P.7
  • 67
    • 0036241207 scopus 로고    scopus 로고
    • Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
    • Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 2002, 5:405-414.
    • (2002) Nat. Neurosci. , vol.5 , pp. 405-414
    • Hardingham, G.E.1    Fukunaga, Y.2    Bading, H.3
  • 68
    • 38349101590 scopus 로고    scopus 로고
    • Glutamate uptake is reduced in prefrontal cortex in Huntington's disease
    • Hassel B., Tessler S., Faull R.L., Emson P.C. Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem. Res. 2008, 33:232-237.
    • (2008) Neurochem. Res. , vol.33 , pp. 232-237
    • Hassel, B.1    Tessler, S.2    Faull, R.L.3    Emson, P.C.4
  • 69
    • 78349291479 scopus 로고    scopus 로고
    • Nicotinamide improves motor deficits and upregulates PGC-1a and BDNF gene expression in a mouse model of Huntington's disease
    • Hathorn T., Snyder-Keller A., Messer A. Nicotinamide improves motor deficits and upregulates PGC-1a and BDNF gene expression in a mouse model of Huntington's disease. Neurobiol. Dis. 2011, 41:43-50.
    • (2011) Neurobiol. Dis. , vol.41 , pp. 43-50
    • Hathorn, T.1    Snyder-Keller, A.2    Messer, A.3
  • 70
    • 0025885733 scopus 로고
    • Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease
    • Hedreen J.C., Peyser C.E., Folstein S.E., Ross C.A. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 1991, 133:257-261.
    • (1991) Neurosci. Lett. , vol.133 , pp. 257-261
    • Hedreen, J.C.1    Peyser, C.E.2    Folstein, S.E.3    Ross, C.A.4
  • 71
    • 63849154126 scopus 로고    scopus 로고
    • In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease
    • Heng M.Y., Detloff P.J., Wang P.L., Tsien J.Z., Albin R.L. In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. J. Neurosci. 2009, 29:3200-3205.
    • (2009) J. Neurosci. , vol.29 , pp. 3200-3205
    • Heng, M.Y.1    Detloff, P.J.2    Wang, P.L.3    Tsien, J.Z.4    Albin, R.L.5
  • 72
    • 54549087605 scopus 로고    scopus 로고
    • Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice
    • Hickey M.A., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M.S., Chesselet M.F. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 2008, 157:280-295.
    • (2008) Neuroscience , vol.157 , pp. 280-295
    • Hickey, M.A.1    Kosmalska, A.2    Enayati, J.3    Cohen, R.4    Zeitlin, S.5    Levine, M.S.6    Chesselet, M.F.7
  • 75
    • 0141678246 scopus 로고    scopus 로고
    • Standardization and statistical approaches to therapeutic trials in the R6/2 mouse
    • Hockly E., Woodman B., Mahal A., Lewis C.M., Bates G. Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain Res. Bull. 2003, 61:469-479.
    • (2003) Brain Res. Bull. , vol.61 , pp. 469-479
    • Hockly, E.1    Woodman, B.2    Mahal, A.3    Lewis, C.M.4    Bates, G.5
  • 76
    • 36849059148 scopus 로고    scopus 로고
    • The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268
    • Imre G. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. CNS Drug Rev. 2007, 13:444-464.
    • (2007) CNS Drug Rev. , vol.13 , pp. 444-464
    • Imre, G.1
  • 77
    • 77953894712 scopus 로고    scopus 로고
    • Huntington's disease: progress toward effective disease-modifying treatments and a cure
    • Johnson C.D., Davidson B.L. Huntington's disease: progress toward effective disease-modifying treatments and a cure. Hum. Mol. Genet. 2010, 9(R1):R98-R102.
    • (2010) Hum. Mol. Genet. , vol.9 , Issue.R1
    • Johnson, C.D.1    Davidson, B.L.2
  • 79
    • 0035975014 scopus 로고    scopus 로고
    • Natural segmentation of the locomotor behavior of drug-induced rats in a photobeam cage
    • Kafkafi N., Mayo C., Drai D., Golani I., Elmer G. Natural segmentation of the locomotor behavior of drug-induced rats in a photobeam cage. J. Neurosci. Methods 2001, 109:111-121.
    • (2001) J. Neurosci. Methods , vol.109 , pp. 111-121
    • Kafkafi, N.1    Mayo, C.2    Drai, D.3    Golani, I.4    Elmer, G.5
  • 80
    • 0038513718 scopus 로고    scopus 로고
    • SEE locomotor behavior test discriminates C57BL/6J and DBA/2J mouse inbred strains across laboratories and protocol conditions
    • Kafkafi N., Lipkind D., Benjamini Y., Mayo C.L., Elmer G.I., Golani I. SEE locomotor behavior test discriminates C57BL/6J and DBA/2J mouse inbred strains across laboratories and protocol conditions. Behav. Neurosci. 2003, 117:464-477.
    • (2003) Behav. Neurosci. , vol.117 , pp. 464-477
    • Kafkafi, N.1    Lipkind, D.2    Benjamini, Y.3    Mayo, C.L.4    Elmer, G.I.5    Golani, I.6
  • 81
    • 0033033679 scopus 로고    scopus 로고
    • Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length
    • Kehoe P., Krawczak M., Harper P.S., Owen M.J., Jones A.L. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J. Med. Genet. 1999, 36:108-111.
    • (1999) J. Med. Genet. , vol.36 , pp. 108-111
    • Kehoe, P.1    Krawczak, M.2    Harper, P.S.3    Owen, M.J.4    Jones, A.L.5
  • 82
    • 9444251087 scopus 로고    scopus 로고
    • Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration
    • Kenchappa R.S., Diwakar L., Annepu J., Ravindranath V. Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration. FASEB J. 2004, 18:1102-1104.
    • (2004) FASEB J. , vol.18 , pp. 1102-1104
    • Kenchappa, R.S.1    Diwakar, L.2    Annepu, J.3    Ravindranath, V.4
  • 83
    • 0033758653 scopus 로고    scopus 로고
    • Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1
    • Kew J.N., Ducarre J.M., Pflimlin M.C., Mutel V., Kemp J.A. Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1. Neuropharmacology 2001, 40:20-27.
    • (2001) Neuropharmacology , vol.40 , pp. 20-27
    • Kew, J.N.1    Ducarre, J.M.2    Pflimlin, M.C.3    Mutel, V.4    Kemp, J.A.5
  • 84
    • 70949092754 scopus 로고    scopus 로고
    • Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors
    • Kim K.K., Adelstein R.S., Kawamoto S. Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J. Biol. Chem. 2009, 284:31052-31061.
    • (2009) J. Biol. Chem. , vol.284 , pp. 31052-31061
    • Kim, K.K.1    Adelstein, R.S.2    Kawamoto, S.3
  • 85
    • 0030483939 scopus 로고    scopus 로고
    • Dual action of metabotropic glutamate receptor agonists on neuronal excitability and synaptic transmission in spinal ventral horn neurons in vitro
    • King A.E., Liu X.H. Dual action of metabotropic glutamate receptor agonists on neuronal excitability and synaptic transmission in spinal ventral horn neurons in vitro. Neuropharmacology 1996, 35:1673-1680.
    • (1996) Neuropharmacology , vol.35 , pp. 1673-1680
    • King, A.E.1    Liu, X.H.2
  • 86
    • 0032791811 scopus 로고    scopus 로고
    • Neuroprotection by metabotropic glutamate receptor agonists: LY2354740, LY379268 and LY389795
    • Kingston A.E., O'Neill M.J., Lam A., Bales K.R., Monn J.A., Schoepp D.D. Neuroprotection by metabotropic glutamate receptor agonists: LY2354740, LY379268 and LY389795. Eur. J. Pharmacol. 1999, 377:155-165.
    • (1999) Eur. J. Pharmacol. , vol.377 , pp. 155-165
    • Kingston, A.E.1    O'Neill, M.J.2    Lam, A.3    Bales, K.R.4    Monn, J.A.5    Schoepp, D.D.6
  • 89
    • 0001288442 scopus 로고
    • Quantitative genetic analysis of multivariate evolution, applied to brain: body size allometry
    • Lande R. Quantitative genetic analysis of multivariate evolution, applied to brain: body size allometry. Evolution 1979, 30:402-416.
    • (1979) Evolution , vol.30 , pp. 402-416
    • Lande, R.1
  • 90
    • 4644350294 scopus 로고    scopus 로고
    • Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats
    • Lei W., Jiao Y., Del Mar N., Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J. Neurosci. 2004, 24:8289-8299.
    • (2004) J. Neurosci. , vol.24 , pp. 8289-8299
    • Lei, W.1    Jiao, Y.2    Del Mar, N.3    Reiner, A.4
  • 91
    • 0012315645 scopus 로고    scopus 로고
    • Neurotrophin secretion: current facts and future prospects
    • Lessmann V., Gottmann K., Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 2003, 69:341-374.
    • (2003) Prog. Neurobiol. , vol.69 , pp. 341-374
    • Lessmann, V.1    Gottmann, K.2    Malcangio, M.3
  • 92
    • 57349135887 scopus 로고    scopus 로고
    • Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors
    • Leveille F., El Gaamouch F., Gouix E., Lecocq M., Lobner D., Nicole O., Buisson A. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 2008, 22:4258-4271.
    • (2008) FASEB J. , vol.22 , pp. 4258-4271
    • Leveille, F.1    El Gaamouch, F.2    Gouix, E.3    Lecocq, M.4    Lobner, D.5    Nicole, O.6    Buisson, A.7
  • 93
    • 4544293517 scopus 로고    scopus 로고
    • Huntingtin and its role in neuronal degeneration
    • Li S.H., Li X.J. Huntingtin and its role in neuronal degeneration. Neuroscientist 2004, 10:467-475.
    • (2004) Neuroscientist , vol.10 , pp. 467-475
    • Li, S.H.1    Li, X.J.2
  • 94
    • 0032811511 scopus 로고    scopus 로고
    • Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice
    • Li H., Li S.H., Cheng A.L., Mangiarini L., Bates G.P., Li X.J. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum. Mol. Genet. 1999, 8:1227-1236.
    • (1999) Hum. Mol. Genet. , vol.8 , pp. 1227-1236
    • Li, H.1    Li, S.H.2    Cheng, A.L.3    Mangiarini, L.4    Bates, G.P.5    Li, X.J.6
  • 95
    • 14844314896 scopus 로고    scopus 로고
    • Enhanced striatal NR2B-containing N-methyl-d-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease
    • Li L., Murphy T.H., Hayden M.R., Raymond L.A. Enhanced striatal NR2B-containing N-methyl-d-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease. J. Neurophysiol. 2004, 92:2738-2746.
    • (2004) J. Neurophysiol. , vol.92 , pp. 2738-2746
    • Li, L.1    Murphy, T.H.2    Hayden, M.R.3    Raymond, L.A.4
  • 96
    • 0034141567 scopus 로고    scopus 로고
    • Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression
    • Lievens J.C., Bernal F., Forni C., Mahy N., Kerkerian-Le Goff L. Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression. Glia 2000, 29:222-232.
    • (2000) Glia , vol.29 , pp. 222-232
    • Lievens, J.C.1    Bernal, F.2    Forni, C.3    Mahy, N.4    Kerkerian-Le Goff, L.5
  • 98
    • 3042655256 scopus 로고    scopus 로고
    • New replicable anxiety-related measures of wall vs center behavior of mice in the open field
    • Lipkind D., Sakov A., Kafkafi N., Elmer G.I., Benjamini Y., Golani I. New replicable anxiety-related measures of wall vs center behavior of mice in the open field. J. Appl. Physiol. 2004, 97:347-359.
    • (2004) J. Appl. Physiol. , vol.97 , pp. 347-359
    • Lipkind, D.1    Sakov, A.2    Kafkafi, N.3    Elmer, G.I.4    Benjamini, Y.5    Golani, I.6
  • 99
    • 0031059920 scopus 로고    scopus 로고
    • Bursts as a unit of neural information: making unreliable synapses reliable
    • Lisman J.E. Bursts as a unit of neural information: making unreliable synapses reliable. Trends Neurosci. 1997, 20:38-43.
    • (1997) Trends Neurosci. , vol.20 , pp. 38-43
    • Lisman, J.E.1
  • 100
    • 2642590951 scopus 로고    scopus 로고
    • Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus
    • Liu X.B., Munoz A., Jones E.G. Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus. J. Comp. Neurol. 1998, 395:450-465.
    • (1998) J. Comp. Neurol. , vol.395 , pp. 450-465
    • Liu, X.B.1    Munoz, A.2    Jones, E.G.3
  • 101
    • 0037475156 scopus 로고    scopus 로고
    • Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268
    • Lorrain D.S., Baccei C.S., Bristow L.J., Anderson J.J., Varney M.A. Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 2003, 117:697-706.
    • (2003) Neuroscience , vol.117 , pp. 697-706
    • Lorrain, D.S.1    Baccei, C.S.2    Bristow, L.J.3    Anderson, J.J.4    Varney, M.A.5
  • 102
    • 0028933282 scopus 로고
    • Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3
    • Lovinger D.M., McCool B.A. Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3. J. Neurophysiol. 1995, 73:1076-1083.
    • (1995) J. Neurophysiol. , vol.73 , pp. 1076-1083
    • Lovinger, D.M.1    McCool, B.A.2
  • 106
    • 78650868456 scopus 로고    scopus 로고
    • Effects of gender in amyotrophic lateral sclerosis
    • McCombe P.A., Henderson R.D. Effects of gender in amyotrophic lateral sclerosis. Gend. Med. 2010, 7:557-570.
    • (2010) Gend. Med. , vol.7 , pp. 557-570
    • McCombe, P.A.1    Henderson, R.D.2
  • 107
    • 0029860222 scopus 로고    scopus 로고
    • Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells
    • McCool B.A., Pin J.P., Brust P.F., Harpold M.M., Lovinger D.M. Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells. Mol. Pharmacol. 1996, 50:912-922.
    • (1996) Mol. Pharmacol. , vol.50 , pp. 912-922
    • McCool, B.A.1    Pin, J.P.2    Brust, P.F.3    Harpold, M.M.4    Lovinger, D.M.5
  • 108
    • 0033674375 scopus 로고    scopus 로고
    • Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease
    • Meade C.A., Figueredo-Cardenas G., Fusco F.R., Nowak T.S., Pulsinelli W., Reiner A. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease. Exp. Neurol. 2000, 166:307-323.
    • (2000) Exp. Neurol. , vol.166 , pp. 307-323
    • Meade, C.A.1    Figueredo-Cardenas, G.2    Fusco, F.R.3    Nowak, T.S.4    Pulsinelli, W.5    Reiner, A.6
  • 109
    • 0037194221 scopus 로고    scopus 로고
    • Localization of neuronal intranuclear inclusions (NIIs) in the striatum and cortex of the Bates R6/2 transgenic mouse
    • Meade C.A., Deng Y.P., Fusco F., Del Mar N., Hersch S., Goldowitz D., Reiner A. Localization of neuronal intranuclear inclusions (NIIs) in the striatum and cortex of the Bates R6/2 transgenic mouse. J. Comp. Neurol. 2002, 449:241-269.
    • (2002) J. Comp. Neurol. , vol.449 , pp. 241-269
    • Meade, C.A.1    Deng, Y.P.2    Fusco, F.3    Del Mar, N.4    Hersch, S.5    Goldowitz, D.6    Reiner, A.7
  • 112
    • 57349084628 scopus 로고    scopus 로고
    • Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease
    • Miller B.R., Walker A.G., Shah A.S., Barton S.J., Rebec G.V. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J. Neurophysiol. 2008, 100:2205-2216.
    • (2008) J. Neurophysiol. , vol.100 , pp. 2205-2216
    • Miller, B.R.1    Walker, A.G.2    Shah, A.S.3    Barton, S.J.4    Rebec, G.V.5
  • 113
    • 37449011119 scopus 로고    scopus 로고
    • Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
    • Milnerwood A.J., Raymond L.A. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. J. Physiol. 2007, 585:817-831.
    • (2007) J. Physiol. , vol.585 , pp. 817-831
    • Milnerwood, A.J.1    Raymond, L.A.2
  • 116
    • 15644369847 scopus 로고    scopus 로고
    • Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo [3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties
    • Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo [3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem. 1997, 40:528-537.
    • (1997) J. Med. Chem. , vol.40 , pp. 528-537
    • Monn, J.A.1    Valli, M.J.2    Massey, S.M.3    Wright, R.A.4    Salhoff, C.R.5    Johnson, B.G.6    Howe, T.7    Alt, C.A.8    Rhodes, G.A.9    Robey, R.L.10    Griffey, K.R.11    Tizzano, J.P.12    Kallman, M.J.13    Helton, D.R.14    Schoepp, D.D.15
  • 117
    • 0033602516 scopus 로고    scopus 로고
    • Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors
    • Monn J.A., Valli M.J., Massey S.M., Hansen M.M., Kress T.J., Wepsiec J.P., Harkness A.R., Grutsch J.L., Wright R.A., Johnson B.G., Andis S.L., Kingston A.E., Tomlinson R., Lewis R., Griffey K.R., Tizzano J.P., Schoepp D.D. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. J. Med. Chem. 1999, 42:1027-1040.
    • (1999) J. Med. Chem. , vol.42 , pp. 1027-1040
    • Monn, J.A.1    Valli, M.J.2    Massey, S.M.3    Hansen, M.M.4    Kress, T.J.5    Wepsiec, J.P.6    Harkness, A.R.7    Grutsch, J.L.8    Wright, R.A.9    Johnson, B.G.10    Andis, S.L.11    Kingston, A.E.12    Tomlinson, R.13    Lewis, R.14    Griffey, K.R.15    Tizzano, J.P.16    Schoepp, D.D.17
  • 120
    • 0026697724 scopus 로고
    • NeuN, a neuronal specific nuclear protein in vertebrates
    • Mullen R.J., Buck C.R., Smith A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992, 116:201-211.
    • (1992) Development , vol.116 , pp. 201-211
    • Mullen, R.J.1    Buck, C.R.2    Smith, A.M.3
  • 121
    • 0026437728 scopus 로고
    • Molecular diversity of glutamate receptors and implications for brain function
    • Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992, 258:597-603.
    • (1992) Science , vol.258 , pp. 597-603
    • Nakanishi, S.1
  • 122
    • 0027168754 scopus 로고
    • Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study
    • Ohishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J. Comp. Neurol. 1993, 335:252-266.
    • (1993) J. Comp. Neurol. , vol.335 , pp. 252-266
    • Ohishi, H.1    Shigemoto, R.2    Nakanishi, S.3    Mizuno, N.4
  • 126
    • 39249084415 scopus 로고    scopus 로고
    • The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model
    • Peng Q., Masuda N., Jiang M., Li Q., Zhao M., Ross C.A., Duan W. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp. Neurol. 2008, 210:154-163.
    • (2008) Exp. Neurol. , vol.210 , pp. 154-163
    • Peng, Q.1    Masuda, N.2    Jiang, M.3    Li, Q.4    Zhao, M.5    Ross, C.A.6    Duan, W.7
  • 127
    • 33646565030 scopus 로고    scopus 로고
    • The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats
    • Peters J., Kalivas P.W. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats. Psychopharmacology (Berl) 2006, 186:143-914.
    • (2006) Psychopharmacology (Berl) , vol.186 , pp. 143-914
    • Peters, J.1    Kalivas, P.W.2
  • 128
    • 0035234670 scopus 로고    scopus 로고
    • Neurotrophins as synaptic modulators
    • Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2001, 2:24-32.
    • (2001) Nat. Rev. Neurosci. , vol.2 , pp. 24-32
    • Poo, M.M.1
  • 129
    • 0037082198 scopus 로고    scopus 로고
    • Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene
    • Rebec G.V., Barton S.J., Ennis M.D. Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene. J. Neurosci. 2002, 22:RC202.
    • (2002) J. Neurosci. , vol.22
    • Rebec, G.V.1    Barton, S.J.2    Ennis, M.D.3
  • 130
    • 29744431726 scopus 로고    scopus 로고
    • Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment
    • Rebec G.V., Conroy S.K., Barton S.J. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment. Neuroscience 2006, 137:327-336.
    • (2006) Neuroscience , vol.137 , pp. 327-336
    • Rebec, G.V.1    Conroy, S.K.2    Barton, S.J.3
  • 131
    • 0033010987 scopus 로고    scopus 로고
    • Recent advances in understanding the pathogenesis of Huntington's disease
    • Reddy P.H., Williams M., Tagle D.A. Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci. 1999, 22:248-255.
    • (1999) Trends Neurosci. , vol.22 , pp. 248-255
    • Reddy, P.H.1    Williams, M.2    Tagle, D.A.3
  • 132
    • 0023091119 scopus 로고
    • The distribution of proenkephalin-derived peptides in the central nervous system of turtle
    • Reiner A. The distribution of proenkephalin-derived peptides in the central nervous system of turtle. J. Comp. Neurol. 1987, 259:65-91.
    • (1987) J. Comp. Neurol. , vol.259 , pp. 65-91
    • Reiner, A.1
  • 134
    • 37049029416 scopus 로고    scopus 로고
    • R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice
    • Reiner A., Del Mar N., Deng Y.P., Meade C.A., Sun Z., Goldowitz D. R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice. J. Comp. Neurol. 2007, 505:603-737.
    • (2007) J. Comp. Neurol. , vol.505 , pp. 603-737
    • Reiner, A.1    Del Mar, N.2    Deng, Y.P.3    Meade, C.A.4    Sun, Z.5    Goldowitz, D.6
  • 135
    • 80755128076 scopus 로고    scopus 로고
    • Corticostriatal projection neurons - dichotomous types and dichotomous functions
    • article 142
    • Reiner A., Hart N.M., Lei W.L., Deng Y.P. Corticostriatal projection neurons - dichotomous types and dichotomous functions. Front. Neuroanat. 2010, 4. article 142. 10.3389/fnana.2010.00142.
    • (2010) Front. Neuroanat. , vol.4
    • Reiner, A.1    Hart, N.M.2    Lei, W.L.3    Deng, Y.P.4
  • 136
    • 0030812891 scopus 로고    scopus 로고
    • Transforming growth factor-b protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-b type II receptor
    • Ren R.F., Hawver D.B., Kim R.S., Flanders K.C. Transforming growth factor-b protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-b type II receptor. Mol. Brain Res. 1997, 48:315-322.
    • (1997) Mol. Brain Res. , vol.48 , pp. 315-322
    • Ren, R.F.1    Hawver, D.B.2    Kim, R.S.3    Flanders, K.C.4
  • 137
    • 0028071467 scopus 로고
    • Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus
    • Richfield E.K., Herkenham M. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann. Neurol. 1994, 36:577-584.
    • (1994) Ann. Neurol. , vol.36 , pp. 577-584
    • Richfield, E.K.1    Herkenham, M.2
  • 138
    • 0026062661 scopus 로고
    • Heterogeneous dopamine receptor changes in early and late Huntington's disease
    • Richfield E.K., O'Brien C.F., Eskin T., Shoulson I. Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neurosci. Lett. 1991, 132:121-126.
    • (1991) Neurosci. Lett. , vol.132 , pp. 121-126
    • Richfield, E.K.1    O'Brien, C.F.2    Eskin, T.3    Shoulson, I.4
  • 139
    • 0029586383 scopus 로고
    • Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients
    • Richfield E.K., Maguire-Zeiss K.A., Vonkeman H.E., Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann. Neurol. 1995, 38:852-861.
    • (1995) Ann. Neurol. , vol.38 , pp. 852-861
    • Richfield, E.K.1    Maguire-Zeiss, K.A.2    Vonkeman, H.E.3    Voorn, P.4
  • 140
    • 0018004847 scopus 로고
    • Picture thresholding using an iterative selection method
    • Ridler T.W., Calvard S. Picture thresholding using an iterative selection method. IEEE Trans. Syst. Man Cybern. 1978, 8:630-632.
    • (1978) IEEE Trans. Syst. Man Cybern. , vol.8 , pp. 630-632
    • Ridler, T.W.1    Calvard, S.2
  • 144
    • 0028873186 scopus 로고
    • Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis
    • Sapp E., Ge P., Aizawa H., Bird E., Penney J., Young A.B., Vonsattel J.P., DiFiglia M. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 1995, 64:397-404.
    • (1995) Neuroscience , vol.64 , pp. 397-404
    • Sapp, E.1    Ge, P.2    Aizawa, H.3    Bird, E.4    Penney, J.5    Young, A.B.6    Vonsattel, J.P.7    DiFiglia, M.8
  • 145
    • 0031036195 scopus 로고    scopus 로고
    • Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors
    • Scanziani M., Salin P.A., Vogt K.E., Malenka R.C., Nicoll R.A. Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature 1997, 385:630-634.
    • (1997) Nature , vol.385 , pp. 630-634
    • Scanziani, M.1    Salin, P.A.2    Vogt, K.E.3    Malenka, R.C.4    Nicoll, R.A.5
  • 147
    • 4043164771 scopus 로고    scopus 로고
    • The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's Disease
    • Schiefer J., Sprünken A., Puls C., Lüesse H.G., Milkereit A., Milkereit E., Johann V., Kosinski C.M. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's Disease. Brain Res. 2004, 1019:246-254.
    • (2004) Brain Res. , vol.1019 , pp. 246-254
    • Schiefer, J.1    Sprünken, A.2    Puls, C.3    Lüesse, H.G.4    Milkereit, A.5    Milkereit, E.6    Johann, V.7    Kosinski, C.M.8
  • 148
    • 0034811597 scopus 로고    scopus 로고
    • Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system
    • Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 2001, 299:12-20.
    • (2001) J. Pharmacol. Exp. Ther. , vol.299 , pp. 12-20
    • Schoepp, D.D.1
  • 149
    • 0032834028 scopus 로고    scopus 로고
    • Pharmacological agents acting at subtypes of metabotropic glutamate receptors
    • Schoepp D.D., Jane D.E., Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 1999, 38:1431-1476.
    • (1999) Neuropharmacology , vol.38 , pp. 1431-1476
    • Schoepp, D.D.1    Jane, D.E.2    Monn, J.A.3
  • 150
    • 0032191581 scopus 로고    scopus 로고
    • Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease
    • Shear D.A., Dong J., Gundy C.D., Haik-Creguer K.L., Dunbar G.L. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22:1217-1240.
    • (1998) Prog. Neuropsychopharmacol. Biol. Psychiatry , vol.22 , pp. 1217-1240
    • Shear, D.A.1    Dong, J.2    Gundy, C.D.3    Haik-Creguer, K.L.4    Dunbar, G.L.5
  • 151
    • 30744437894 scopus 로고    scopus 로고
    • Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease
    • Shehadeh J., Fernandes H.B., Zeron Mullins M.M., Graham R.K., Leavitt B.R., Hayden M.R., Raymond L.A. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol. Dis. 2006, 21:392-403.
    • (2006) Neurobiol. Dis. , vol.21 , pp. 392-403
    • Shehadeh, J.1    Fernandes, H.B.2    Zeron Mullins, M.M.3    Graham, R.K.4    Leavitt, B.R.5    Hayden, M.R.6    Raymond, L.A.7
  • 152
    • 29144460321 scopus 로고    scopus 로고
    • Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
    • Shin J.Y., Fang Z.H., Yu Z.X., Wang C.E., Li S.H., Li X.J. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol. 2005, 171:1001-1012.
    • (2005) J. Cell Biol. , vol.171 , pp. 1001-1012
    • Shin, J.Y.1    Fang, Z.H.2    Yu, Z.X.3    Wang, C.E.4    Li, S.H.5    Li, X.J.6
  • 153
    • 78650599933 scopus 로고    scopus 로고
    • Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice
    • Simmons D.A., Mehta R.A., Lauterborn J.C., Gall C.M., Lynch G. Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice. Neurobiol. Dis. 2011, 41:436-444.
    • (2011) Neurobiol. Dis. , vol.41 , pp. 436-444
    • Simmons, D.A.1    Mehta, R.A.2    Lauterborn, J.C.3    Gall, C.M.4    Lynch, G.5
  • 155
    • 0025341024 scopus 로고
    • Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence
    • Somers D.L., Beckstead R.M. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence. Mol. Brain Res. 1990, 8:143-158.
    • (1990) Mol. Brain Res. , vol.8 , pp. 143-158
    • Somers, D.L.1    Beckstead, R.M.2
  • 156
    • 0032568534 scopus 로고    scopus 로고
    • Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
    • Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6469-6473.
    • (1998) Proc. Natl. Acad. Sci. U. S. A. , vol.95 , pp. 6469-6473
    • Spillantini, M.G.1    Crowther, R.A.2    Jakes, R.3    Hasegawa, M.4    Goedert, M.5
  • 159
  • 160
    • 66749167799 scopus 로고    scopus 로고
    • Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity
    • Subramaniam S., Sixt K.M., Barrow R., Snyder S.H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 2009, 324:1327-1330.
    • (2009) Science , vol.324 , pp. 1327-1330
    • Subramaniam, S.1    Sixt, K.M.2    Barrow, R.3    Snyder, S.H.4
  • 161
    • 0037004869 scopus 로고    scopus 로고
    • Differential changes in striatal projection neurons in R6/2 mice transgenic for Huntington's disease
    • Sun Z., Del Mar N., Meade C., Goldowitz D., Reiner A. Differential changes in striatal projection neurons in R6/2 mice transgenic for Huntington's disease. Neurobiol. Dis. 2002, 11:369-385.
    • (2002) Neurobiol. Dis. , vol.11 , pp. 369-385
    • Sun, Z.1    Del Mar, N.2    Meade, C.3    Goldowitz, D.4    Reiner, A.5
  • 162
    • 77956434789 scopus 로고    scopus 로고
    • Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease
    • Tallaksen-Greene S.J., Janiszewska A., Benton K., Lech Ruprecht L., Albin R.L. Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease. Exp. Neurol. 2010, 225:402-407.
    • (2010) Exp. Neurol. , vol.225 , pp. 402-407
    • Tallaksen-Greene, S.J.1    Janiszewska, A.2    Benton, K.3    Lech Ruprecht, L.4    Albin, R.L.5
  • 163
    • 0035875713 scopus 로고    scopus 로고
    • AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter
    • Tekkok S.B., Goldberg M.P. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J. Neurosci. 2001, 21:4237-4248.
    • (2001) J. Neurosci. , vol.21 , pp. 4237-4248
    • Tekkok, S.B.1    Goldberg, M.P.2
  • 164
    • 0028270378 scopus 로고
    • Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
    • Testa C.M., Standaert D.G., Young A.B., Penney J.B. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 1994, 14:3005-3008.
    • (1994) J. Neurosci. , vol.14 , pp. 3005-3008
    • Testa, C.M.1    Standaert, D.G.2    Young, A.B.3    Penney, J.B.4
  • 165
    • 17644368893 scopus 로고    scopus 로고
    • Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
    • Van Raamsdonk J.M., Pearson J., Slow E.J., Hossain S.M., Leavitt B.R., Hayden M.R. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci. 2005, 25:4169-4180.
    • (2005) J. Neurosci. , vol.25 , pp. 4169-4180
    • Van Raamsdonk, J.M.1    Pearson, J.2    Slow, E.J.3    Hossain, S.M.4    Leavitt, B.R.5    Hayden, M.R.6
  • 167
    • 33645109430 scopus 로고    scopus 로고
    • Single-cell RT-PCR, in situ hybridization histochemical, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats
    • Wang H.B., Laverghetta A.V., Foehring R.F., Deng Y.P., Sun Z., Yamamoto K., Lei W.L., Jiao Y., Reiner A. Single-cell RT-PCR, in situ hybridization histochemical, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats. J. Chem. Neuroanat. 2006, 31:178-199.
    • (2006) J. Chem. Neuroanat. , vol.31 , pp. 178-199
    • Wang, H.B.1    Laverghetta, A.V.2    Foehring, R.F.3    Deng, Y.P.4    Sun, Z.5    Yamamoto, K.6    Lei, W.L.7    Jiao, Y.8    Reiner, A.9
  • 169
    • 78049525220 scopus 로고    scopus 로고
    • BDNF Overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice
    • Xie Y., Hayden M.R., Xu B. BDNF Overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice. J. Neurosci. 2010, 30:14708-14718.
    • (2010) J. Neurosci. , vol.30 , pp. 14708-14718
    • Xie, Y.1    Hayden, M.R.2    Xu, B.3
  • 170
    • 0037209247 scopus 로고    scopus 로고
    • Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex
    • Zhai Y., George C.A., Zhai J., Nisenbaum E.S., Johnson M.P., Nisenbaum L.K. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex. Neuropsychopharmacology 2003, 28:45-52.
    • (2003) Neuropsychopharmacology , vol.28 , pp. 45-52
    • Zhai, Y.1    George, C.A.2    Zhai, J.3    Nisenbaum, E.S.4    Johnson, M.P.5    Nisenbaum, L.K.6
  • 171
    • 33749166779 scopus 로고    scopus 로고
    • Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala
    • Zhao Y., Dayas C.V., Aujula H., Baptista M.A., Martin-Fardon R., Weiss F. Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala. J. Neurosci. 2006, 26:9967-9974.
    • (2006) J. Neurosci. , vol.26 , pp. 9967-9974
    • Zhao, Y.1    Dayas, C.V.2    Aujula, H.3    Baptista, M.A.4    Martin-Fardon, R.5    Weiss, F.6
  • 172
    • 34047130812 scopus 로고    scopus 로고
    • Role of brain-derived neurotrophic factor in Huntington's disease
    • Zuccato C., Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 2007, 81:294-330.
    • (2007) Prog. Neurobiol. , vol.81 , pp. 294-330
    • Zuccato, C.1    Cattaneo, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.